NCT04238481View on ClinicalTrials.gov

A Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

November 18, 2021

Study Completion Date

November 29, 2021

Conditions
Laparoscopic/Minimally Invasive Colorectal Surgery
Interventions
DRUG

Pudexacianinium chloride

Intravenous

Trial Locations (2)

32804

Center for Colon and Rectal Surgery; AdventHealth Medical Group, Orlando

70121

Ochsner Medical Center, New Orleans

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT04238481 - A Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery | Biotech Hunter | Biotech Hunter